Maquet/Datascope Intra-Aortic Balloon Pump Recall Issued Due to Battery Pump Failures Linked to Patient Deaths

More than 20,000 cardiac assist devices used in hospitals nationwide have been recalled, due to a risk that the battery may lose charge and stop working unexpectedly, which may have been linked to at least five patient deaths.

The FDA announced the Maquet/Datascope Intra-Aortic Balloon Pump recall on July 23, indicating that design defect in the batteries used to power the devices may cause the device to be prone to losing charge, stopping unexpectedly, and having shortened run-time. These problems may cause the balloon pump to stop working.

To date, the manufacturer has become aware of five patient deaths while using the recalled devices. However, an investigation is still ongoing to determine whether the battery failure defect contributed to the fatalities.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Intra-Aortic Balloon Pumps (IABP) are cardiac assist devices used during patient cardiac and non-cardiac surgeries. The devices are also used to treat patients with acute coronary syndrome or complications from heart failure.

FDA officials are warning healthcare professionals that patients using IABP devices for life-supporting therapy may be at an increased risk of severe injuries or death in the event the battery experiences complications during use.

The recall includes all lot numbers of the Cardiosave Hybrid IABP, Cardiosave Rescue IABP, CS300 IABP and CS100/100i IABP models manufactured by Maquet/Datascope of Wayne, New Jersey. The devices were distributed for sale across the United States to medical centers and hospitals.

On June 17, 2019, the manufacturer issued an Urgent Medical Device Correction notice informing customers of the potential risk of battery failure, and listed a series of instructions to follow to ensure patient safety.

The manufacturer recall notice warns that customers should ensure the IABP is plugged into an AC power outlet when the system is not is use, and whenever possible during patient use. The battery run time should be checked frequently and replaced with only Datascope-approved replacement batteries, as recommended in the Operating Instructions Manual.

Maquet/Datascope announced they are currently working on developing a Cardiosave battery maintenance software upgrade, expected to be ready in early 2020. Once the software upgrade is cleared by the FDA, the manufacturer will begin notifying customers to schedule the installation.

The FDA has categorized this recall as a Class I, indicating it is the most serious type of recall and that the use of these devices may cause serious injuries or death to patients.

Customers with additional questions or concerns regarding the recall may contact Maquet/Datascope Technical Support Department at 1-888-627-8383. All adverse events involving the recalled devices should be reported to the FDA’s MedWatch Adverse Event Reporting Program.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted today)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.

Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024
Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024 (Posted 3 days ago)

A federal judge is allowing plaintiffs to file large numbers of Suboxone tooth decay lawsuits in one bundled complaint, to meet a potential two-year statute of limitations deadline, with the ability to flesh those claims out in more detail at a later date.